Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4754 | QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 5.33 USD | -4.31% | +7.03% | +26.90% | -42.81% | 10.70 M USD | ||
| 4755 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 7.90 USD | -0.88% | +3.27% | +12.70% | +406.41% | 11.08 M USD | ||
| 4765 | VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.24 USD | 0.00% | -7.69% | +4.35% | -53.85% | 10.65 M USD | ||
| 4767 | TOVX Theriva Biologics, Inc. Common Stock | 0.24 USD | +4.35% | +4.35% | +9.09% | -4.00% | 11.01 M USD | ||
| 4778 | SKYE Skye Bioscience, Inc. - Common Stock | 2.11 USD | +653.57% | +283.64% | +224.62% | +163.75% | 74.74 M USD | ||
| 4779 | LNAI Lunai Bioworks Inc. - Common Stock | 2.17 USD | 0.00% | -1.36% | -8.05% | +40.00% | 9.84 M USD | ||
| 4786 | MTVA MetaVia Inc. - Common Stock | 1.45 USD | -0.68% | -0.68% | -2.68% | +123.08% | 9.55 M USD | ||
| 4789 | FBLG FibroBiologics, Inc. - Common Stock | 1.38 USD | -4.17% | +23.21% | +102.94% | +126.23% | 9.19 M USD | ||
| 4790 | AEON AEON Biopharma, Inc. Class A Common Stock | 0.19 USD | 0.00% | -29.63% | -24.00% | -81.73% | 9.48 M USD | ||
| 4797 | IMNN Imunon, Inc. - Common Stock | 1.63 USD | -0.61% | 0.00% | +7.24% | -49.85% | 9.15 M USD | ||
| 4809 | CNSP CNS Pharmaceuticals, Inc. - Common Stock | 5.85 USD | -2.01% | +6.17% | +15.16% | -6.10% | 8.55 M USD | ||
| 4812 | SNGX Soligenix, Inc. - Common Stock | 0.40 USD | 0.00% | +2.56% | +8.11% | -64.60% | 8.71 M USD | ||
| 4813 | CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 1.26 USD | -3.82% | +14.55% | +59.49% | -59.62% | 8.31 M USD | ||
| 4819 | XBIO Xenetic Biosciences, Inc. - Common Stock | 3.87 USD | +7.80% | +21.70% | +54.18% | +28.57% | 9.07 M USD | ||
| 4827 | TRAW Traws Pharma, Inc. - Common Stock | 0.54 USD | +1.89% | 0.00% | +10.20% | -62.24% | 8.30 M USD | ||
| 4831 | APRE Aprea Therapeutics, Inc. - Common Stock | 0.69 USD | +7.81% | 0.00% | +4.55% | -58.18% | 8.69 M USD | ||
| 4836 | ERNA Ernexa Therapeutics Inc. - Common Stock | 4.89 USD | +0.62% | +15.06% | +25.71% | +1297.14% | 7.98 M USD | ||
| 4837 | AIM AIM ImmunoTech Inc. Common Stock | 0.25 USD | -3.85% | +4.17% | 0.00% | -90.67% | 7.61 M USD | ||
| 4839 | AZTR Azitra Inc Common Stock | 0.13 USD | 0.00% | -7.14% | 0.00% | -18.75% | 7.88 M USD | ||
| 4844 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.49 USD | +1.36% | -1.32% | +3.47% | -22.40% | 7.85 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |